Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chrystia Zobniw

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancer Journal (Sudbury, Mass.)|April 26, 2016
Managing Adverse Events With Immune Checkpoint AgentsRamona Dadu, Chrystia Zobniw, Adi Diab
Expert Opinion on Drug Safety|June 20, 2017
The efficacy and safety of adjuvant interferon-alfa therapy in the evolving treatment landscape for resected high-risk melanomaVan Anh Trinh, Chrystia Zobniw, Wen-Jen Hwu
The Annals of Pharmacotherapy|April 5, 2018
Avelumab: A Review of Its Application in Metastatic Merkel Cell CarcinomaJocelyn Joseph, Chrystia Zobniw, Jennifer Davis, et al.
Inflammatory Bowel Diseases|May 3, 2018
Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related ColitisYinghong Wang, Hamzah Abu-Sbeih, Emily Mao, et al.
Cancer Cell|May 10, 2022
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunityYared Hailemichael, Daniel H Johnson, Noha Abdel-Wahab, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancer Journal (Sudbury, Mass.)|April 26, 2016
Managing Adverse Events With Immune Checkpoint AgentsRamona Dadu, Chrystia Zobniw, Adi Diab
Expert Opinion on Drug Safety|June 20, 2017
The efficacy and safety of adjuvant interferon-alfa therapy in the evolving treatment landscape for resected high-risk melanomaVan Anh Trinh, Chrystia Zobniw, Wen-Jen Hwu
The Annals of Pharmacotherapy|April 5, 2018
Avelumab: A Review of Its Application in Metastatic Merkel Cell CarcinomaJocelyn Joseph, Chrystia Zobniw, Jennifer Davis, et al.
Inflammatory Bowel Diseases|May 3, 2018
Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related ColitisYinghong Wang, Hamzah Abu-Sbeih, Emily Mao, et al.
Cancer Cell|May 10, 2022
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunityYared Hailemichael, Daniel H Johnson, Noha Abdel-Wahab, et al.
Pageof 1